Conference Description
Key Speakers Include:-
Arun Bhatt, President, Clininvent Research
R. H. Jani, Senior Vice President, Clinical R&D, Cadila
Purnima Sharma, Managing Director, Biotech Consortium India Limited BCIL
Annaswamy Vaidheesh, Vice President- Government affairs Asia Pacific, Johnson & Johnson
Bobby George, Asssitant Vice President and Head, Regulatory Affairs, Reliance Life Sciences
Dilip Pawar, Director and Head Clinical Development, Dr Reddys
Kaustubh Berde, Vice President & Head - International Formulations, Panacea Biotec
Yatin Gokarn, Narotam Sekhsaria Distinguished Professor of Chemical Engineering, Institute of Chemical Technology.
(Former Associate Director, Genentech (San Francisco)
Anurita Majumdar, Director - Medical & Regulatory - India & South Africa, Eli Lilly
Chirag Trivedi, Associate Director - Project Management & Strategic Initiatives, Sanofi-Aventis
Kedar Suvarnapathaki, Head - Regulatory Affair, Boehringer Ingelheim
Yasmin Shenoy, Director-Regulatory Affairs, Sanofi-Aventis
Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
Plus Many More...
To know more about conferences on :
The recent establishment of regulatory guidelines for biosimilars in India is expected to add further momentum to the growth of the global
biosimilars market. Increasing pressure from governments and insurers
for greater biologic competition, there exists an incredible opportunity
for biosimilar producers to capitalise on what is set to become the
fastest growing sector of the pharmaceutical industry. Due to the
limited clinical database at the time of approval of a biosimilar,
vigorous pharmacovigilance is required. & Biosimilars are set to
become an important part of the future medicines market.
To know more about conferences on :